tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Kevin Fischbeck, 30 are a SELL (18.52%), 89 are a BUY (54.94%), 43 are a HOLD (26.54%).
Analyst Kevin Fischbeck, currently employed at BAML, carries an average stock price target met ratio of 67.88% that have a potential upside of 24.81% achieved within 202 days.
Kevin Fischbeck’s has documented 322 price targets and ratings displayed on 29 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on THC, Tenet Healthcare at 10-Sep-2025.
Analyst best performing recommendations are on CLOV (CLOVER HEALTH INVESTMENTS CORP).
The best stock recommendation documented was for UHS (UNIVERSAL HEALTH SERVICES) at 3/23/2020. The price target of $104 was fulfilled within 16 days with a profit of $33.74 (48.02%) receiving and performance score of 30.01.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$1.4
$0.27 (23.89%)
$2.5
1 months 20 days ago
(19-Aug-2025)
1/2 (50%)
$0.19 (15.70%)
33
Hold
$1
$-0.13 (-11.50%)
$5
1 months 26 days ago
(13-Aug-2025)
3/3 (100%)
$-0.06 (-5.66%)
28
Sell
$1.5
$0.37 (32.74%)
$3
2 months 4 days ago
(05-Aug-2025)
2/3 (66.67%)
$0.61 (68.54%)
1
Hold
$1
$-0.13 (-11.50%)
$5
2 months 4 days ago
(05-Aug-2025)
4/5 (80%)
$0.11 (12.36%)
43
Buy
$1.5
$0.37 (32.74%)
$9
2 months 4 days ago
(05-Aug-2025)
0/5 (0%)
$0.61 (68.54%)
Which stock is Kevin Fischbeck is most bullish on?
Which stock is Kevin Fischbeck is most reserved on?
What Year was the first public recommendation made by Kevin Fischbeck?
